ESMO 2016: Industry Sponsored Satellite Symposia

Click on the links below to access the Industry Sponsored Satellite Symposia Invitations.

Friday 7 October 2016

Treating mRCC: Clinical Considerations in an Evolving Treatment Landscape

Treating mRCC: Clinical Considerations in an Evolving Treatment Landscape square

Friday, 18:00-19:30
View the satellite invitation 

The Science and Application of Checkpoint Inhibitors Across Melanoma, Head and Neck, and Genitourinary Cancers: What Have We Learned and Next Steps?

The Science and Application of Checkpoint Inhibitors Across Melanoma, Head and Neck, and Genitourinary Cancers square

Friday, 18:00-20:00
View the satellite invitation 

The Transformation From CRPC Into Bone-Migrated Prostate Cancer

The Transformation From CRPC Into Bone-Migrated Prostate Cancer square

Friday, 18:00-20:00
View the satellite invitation 

Finding Solutions to Difficult Problems in HER2-Positive Breast Cancer

Finding Solutions to Difficult Problems in HER2-Positive Breast Cancer

Friday, 18:00-20:00
View the satellite invitation 

When and Why Should I Use Chemotherapy to Treat Patients with Prostate Cancer?

When and Why Should I Use Chemotherapy to Treat Patients with Prostate Cancer square

Friday, 18:00-20:00
View the satellite invitation 

Targeted Treatments in Ovarian Cancer Right Patient Right Treatment Right Time

Targeted Treatments in Ovarian Cancer Right Patient Right Treatment Right Time square

Friday, 18:00-20:00
View the satellite invitation 

Optimising Today, Considerations for Tomorrow: Treating Advanced RCC in an Evolving Landscape

Optimising Today, Considerations for Tomorrow: Treating Advanced RCC in an Evolving Landscape square

Friday, 18:00-20:00
View the satellite invitation 

Safeguarding the Future of Cancer Care in Europe Demands Different Thinking: Optimising the Use of Resources

Safeguarding the Future of Cancer Care in Europe Demands Different Thinking Optimising the Use of Resources square

Friday, 18:30-19:00
View the satellite invitation 

Saturday 8 October 2016

Advanced GI Cancer Care: Evolutions and Revolutions

Advanced GI Cancer Care: Evolutions and Revolutions square

Saturday, 13:00-14:30
View the satellite invitation

Immuno-Oncology in GU Cancer: Where Are We Today? Where Do We Go From Here?

Immuno-Oncology in GU Cancer: Where Are We Today? Where Do We Go From Here? square

Saturday, 13:00-14:30
View the satellite invitation

Navigating the Future for HR+/HER2– Metastatic Breast Cancer

Navigating the future for HR+/HER2– metastatic breast cancer square

Saturday, 13:00-14:30
View the satellite invitation

Looking Beyond the Curve in BRAF: Mutant Metastatic Melanoma

Looking Beyond the Curve in BRAF: Mutant Metastatic Melanoma square

Saturday, 18:30–20:00
View the satellite invitation

Combination Therapy Approaches for Breast Cancer Stepping From Current Options to the Future

Combination Therapy Approaches for Breast Cancer Stepping From Current Options to the Future square

Saturday, 18:30–20:00
View the satellite invitation

Management of Advanced Renal Cell Carcinoma in the Spotlight Important Changes are Occurring

Management of Advanced Renal Cell Carcinoma in the Spotlight Important Changes are Occurring square

Saturday, 18:30–20:00
View the satellite invitation

The Role of Immune Checkpoint Inhibitors Across Multiple Tumor Types

The Role of Immune Checkpoint Inhibitors Across Multiple Tumor Types

Saturday, 18:30-20:00
View the satellite invitation

Sunday 9 October 2016

Immuno-Oncology A Renaissance in the Treatment of NSCLC

Immuno-Oncology A Renaissance in the Treatment of NSCLC square

Sunday, 13:00-14:30
View the invitation

Immuno-Oncology: Current Developments and Clinical Directions in Lung and Head & Neck Cancers

Immuno-Oncology: Current Developments and Clinical Directions in Lung and Head & Neck Cancers square

Sunday, 13:00-14:30
View the invitation

ALK and ROS1 in NSCLC: Optimising the continuum of care

ALK and ROS1 in NSCLC: Optimising the continuum of care

Sunday, 13:00-14:30
View the invitation

The Future of Checkpoint Inhibition in Cancer: Are We About to Challenge the Standard of Care in Triple-Negative Breast Cancer and Gastric and Colorectal Cancers?

The Future of Checkpoint Inhibition in Cancer square

Sunday, 18:30-20:00
View the satellite invitation 

Controlling Disease Progression in Metastatic Colorectal Cancer Steps Towards Understanding Tumor Evolution

Controlling Disease Progression in Metastatic Colorectal Cancer Steps Towards Understanding Tumor Evolution square

Sunday, 18:30-20:00
View the satellite invitation 

Developing Biosimilar mAbs in Breast Cancer What are the Critical Components for Clinical Confidence

Developing Biosimilar mAbs in Breast Cancer What are the Critical Components for Clinical Confidence square

Sunday, 18:30-20:00
View the satellite invitation 

Monday 10 October 2016

Advanced NSCLC: Navigating the Revolution

Advanced NSCLC: Navigating the Revolution square

Monday, 13:00-14:30
View the satellite invitation

Making the Right Choices for Your Melanoma Patients in the Era of Combination Therapies: An Interactive Discussion

Making the Right Choices for Your Melanoma Patients in the Era of Combination Therapies: An Interactive Discussion square

Monday, 13:00-14:30
View the satellite invitation

Progress Beyond Progression a new Treatment Option for Advanced RCC in 2016

Progress Beyond Progression a new Treatment Option for Advanced RCC in 2016 square

Monday, 13:00-14:30
View the satellite invitation

Next Generation Management of ER+ve HER2-ve Advanced Breast Cancer

Next Generation Management of ER+ve HER2-ve Advanced Breast Cancer square

Monday, 13:00-14:30
View the satellite invitation

Novel Approaches to Active Immunotherapy in Oncology – Targeting Globo Series with Adagloxad Simolenin

Novel Approaches to Active Immunotherapy in Oncology Targeting Globo Series with Adagloxad Simolenin

Monday, 18:30-20:00
View the satellite invitation

Optimizing Treatment for Patients with ALK+ NSCLC

Optimizing Treatment for Patients with ALK+ NSCLC square

Monday, 18:30-20:00
View the satellite invitation

Coming of Age of CDK 4-6 Inhibitors

Coming of Age of CDK 4-6 Inhibitors square

Monday, 18:30-20:00
View the satellite invitation

DNA Damage Response Potential to Change the Paradigm in Cancer Treatment

DNA Damage Response Potential to Change the Paradigm in Cancer Treatment square

Monday, 18:30-20:00
View the satellite invitation

Progress in the Treatment of Advanced Breast Cancer: Spotlight on Selective CDK4 & 6 Inhibitors

Spotlight on selective CDK4&6 inhibitors

Monday, 18:30-20:00
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.

View the Complete ESMO 2016 Industry Satellite Symposia Programme